GlassScriptPhysician profile
David B Moats
NPI 1154395069
$1,439.00
in general payments reported to CMS, 2019-2025
22 companies · $208 in 2025
The $208 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $303 · 2021: $267 · 2022: $174 · 2023: $313 · 2024: $174 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $695.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $695.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $243.68 | 2019-2024 | Puraply |
| Bioventus LLC | $185.46 | 2021-2025 | Exogen Ultrasound Bone Healing System, Stimrouter Implantable Kit, Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $143.00 | 2019-2025 | Collagenase Santyl, Grafix Pl |
| Melinta Therapeutics, LLC | $124.99 | 2019 | |
| Paratek Pharmaceuticals, INC. | $98.61 | 2021-2023 | Nuzyra |
| Bard Peripheral Vascular, INC. | $77.25 | 2021 | |
| Abbott Laboratories | $73.91 | 2023-2024 | Proclaim, Axium |
| Depuy Synthes Sales INC. | $60.79 | 2022-2024 | |
| Acera Surgical, INC. | $59.42 | 2022-2023 | Restrata Wound Matrix |
| Medtronic, INC. | $51.50 | 2024-2025 | Intellis Adaptivestim, Hawkone |
| Averitas Pharma INC. | $44.15 | 2023 | Qutenza |
| Kerecis Limited | $41.61 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen |
| Integra Lifesciences Corporation | $33.56 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Nevro Corp. | $33.55 | 2023 | Senza |
| Globus Medical, INC. | $26.97 | 2025 | Senza |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $24.99 | 2019 | |
| Sebela Pharmaceuticals INC. | $23.64 | 2021 | |
| Stryker Corporation | $23.34 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $21.29 | 2023 | Seglentis |
| Reel Surgical, INC. | $17.52 | 2024 | |
| Next Science LLC | $16.14 | 2024 | Blastx, Surgx, Xperience |
| Reprise Biomedical, INC. | $13.63 | 2025 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Moats listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.